377 related articles for article (PubMed ID: 38456493)
1. Revolutionizing breast cancer treatment: Harnessing the related mechanisms and drugs for regulated cell death (Review).
Ai L; Yi N; Qiu C; Huang W; Zhang K; Hou Q; Jia L; Li H; Liu L
Int J Oncol; 2024 May; 64(5):. PubMed ID: 38456493
[TBL] [Abstract][Full Text] [Related]
2. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
[TBL] [Abstract][Full Text] [Related]
3. Iron and copper: critical executioners of ferroptosis, cuproptosis and other forms of cell death.
Li Y; Du Y; Zhou Y; Chen Q; Luo Z; Ren Y; Chen X; Chen G
Cell Commun Signal; 2023 Nov; 21(1):327. PubMed ID: 37974196
[TBL] [Abstract][Full Text] [Related]
4. Regulated Cell Death in Endometriosis.
Huang E; Wang X; Chen L
Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397379
[TBL] [Abstract][Full Text] [Related]
5. Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.
Liao M; Qin R; Huang W; Zhu HP; Peng F; Han B; Liu B
J Hematol Oncol; 2022 Apr; 15(1):44. PubMed ID: 35414025
[TBL] [Abstract][Full Text] [Related]
6. From ferroptosis to cuproptosis, and calcicoptosis, to find more novel metals-mediated distinct form of regulated cell death.
Gu J; Guo C; Ruan J; Li K; Zhou Y; Gong X; Shi H
Apoptosis; 2024 Jun; 29(5-6):586-604. PubMed ID: 38324163
[TBL] [Abstract][Full Text] [Related]
7. Regulated cell death in cancer: from pathogenesis to treatment.
Gong L; Huang D; Shi Y; Liang Z; Bu H
Chin Med J (Engl); 2023 Mar; 136(6):653-665. PubMed ID: 35950752
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis and cuproptposis in kidney Diseases: dysfunction of cell metabolism.
Chen T; Liang L; Wang Y; Li X; Yang C
Apoptosis; 2024 Apr; 29(3-4):289-302. PubMed ID: 38095762
[TBL] [Abstract][Full Text] [Related]
9. Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms.
Li R; Wu Y; Li Y; Shuai W; Wang A; Zhu Y; Hu X; Xia Y; Ouyang L; Wang G
Eur J Med Chem; 2024 Feb; 265():116040. PubMed ID: 38142509
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis, Pyroptosis, and Cuproptosis in Alzheimer's Disease.
Wang Q; Sun J; Chen T; Song S; Hou Y; Feng L; Fan C; Li M
ACS Chem Neurosci; 2023 Oct; 14(19):3564-3587. PubMed ID: 37703318
[TBL] [Abstract][Full Text] [Related]
11. Regulated Necrotic Cell Death in Alternative Tumor Therapeutic Strategies.
Woo Y; Lee HJ; Jung YM; Jung YJ
Cells; 2020 Dec; 9(12):. PubMed ID: 33348858
[TBL] [Abstract][Full Text] [Related]
12. Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer.
Liu X; Luo B; Wu X; Tang Z
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):189013. PubMed ID: 37918452
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application.
Liu N; Chen M
Biomed Pharmacother; 2024 Feb; 171():116115. PubMed ID: 38181713
[TBL] [Abstract][Full Text] [Related]
14. Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials.
Wang J; Li J; Liu J; Chan KY; Lee HS; Lin KN; Wang CC; Lau TS
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339263
[TBL] [Abstract][Full Text] [Related]
15. Regulated lytic cell death in breast cancer.
Liu M; Wang L; Xia X; Wu Y; Zhu C; Duan M; Wei X; Hu J; Lei L
Cell Biol Int; 2022 Jan; 46(1):12-33. PubMed ID: 34549863
[TBL] [Abstract][Full Text] [Related]
16. Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma.
Zhang Y; Zhou J; Li H; Liu Y; Li J
BMC Pulm Med; 2023 Jun; 23(1):205. PubMed ID: 37308925
[TBL] [Abstract][Full Text] [Related]
17. Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis.
Nie D; Chen C; Li Y; Zeng C
Blood Sci; 2022 Jul; 4(3):152-154. PubMed ID: 36518588
[TBL] [Abstract][Full Text] [Related]
18. Modes of Regulated Cell Death in Cancer.
Koren E; Fuchs Y
Cancer Discov; 2021 Feb; 11(2):245-265. PubMed ID: 33462123
[TBL] [Abstract][Full Text] [Related]
19. Targeting regulated cell death (RCD) in hematological malignancies: Recent advances and therapeutic potential.
Zhang Y; Zhou X
Biomed Pharmacother; 2024 Jun; 175():116667. PubMed ID: 38703504
[TBL] [Abstract][Full Text] [Related]
20. Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma.
Dong L; Vargas CPD; Tian X; Chu X; Yin C; Wong A; Yang Y
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
